Can Saxenda (Liraglutide) Cause Weight Gain?

How Liraglutide Is Supposed to Work

Saxenda contains liraglutide, a synthetic version of a hormone called GLP-1 that your gut naturally releases after eating. By mimicking GLP-1, liraglutide signals to your brain that you are full, slows the rate at which your stomach empties, and gradually reduces overall appetite. The FDA approved Saxenda for chronic weight management in adults with a BMI above 30, or above 27 when accompanied by a weight-related condition such as high blood pressure or type 2 diabetes.

Clinical trials showed an average weight loss of 5 to 10 percent of body weight over 56 weeks when Saxenda was combined with a reduced-calorie diet and increased physical activity. That range is meaningful, but it is not universal. Some patients respond dramatically; others see modest results. Understanding why those outcomes differ is central to answering whether liraglutide can cause weight gain.

Does Saxenda Directly Cause the Scale to Go Up?

The short answer is that liraglutide does not have a known pharmacological mechanism that causes fat storage or promotes weight gain. Unlike some psychiatric medications or corticosteroids, it does not stimulate pathways associated with increased appetite, fluid retention, or fat deposition.

A small subset of participants in Saxenda clinical trials did not lose weight and some experienced modest increases. Researchers attribute this primarily to compensatory eating behaviors, underlying metabolic conditions, or concurrent medications rather than to the drug itself. Edema, which is swelling caused by fluid retention, is also not a documented feature of liraglutide the way it is with certain diabetes or blood pressure medications.

So while a patient may gain weight while taking Saxenda, the medication is rarely the direct cause. The more productive question is what else might be happening.

Why Some Patients See Unexpected Weight Changes During Treatment

Several real-world factors can shift the scale upward even when a patient is taking Saxenda as prescribed.

During the dose titration phase, when the dose is gradually increased from 0.6 mg to the full 3 mg over several weeks, nausea and vomiting are common. These side effects often cause erratic eating, including skipped meals followed by larger meals, which can disrupt calorie balance in unpredictable ways.

Once a patient reaches a stable dose and the nausea subsides, appetite can partially return. This is sometimes called behavioral rebound. The drug is still working, but the suppression of hunger may feel less dramatic than it did during adjustment, leading some patients to eat more than they did during the early weeks.

Adaptive thermogenesis is another underappreciated factor. As the body loses weight, it becomes more efficient at using calories, effectively slowing metabolism. This can create a plateau that patients sometimes interpret as gain, when the scale is actually just stalling rather than climbing.

Underlying conditions like hypothyroidism or polycystic ovary syndrome can counteract liraglutide's effects, and concomitant medications including certain antidepressants, antipsychotics, and corticosteroids may independently promote weight gain.

Weight Regain After Stopping Saxenda

One of the most important and often underappreciated facts about Saxenda is what happens when patients stop taking it. Research consistently shows that patients may regain roughly two-thirds of their lost weight within one year of discontinuing liraglutide. This is not because the drug damaged their metabolism. It is because the GLP-1 hormone effect disappears quickly after the last dose, and the body's original appetite signals return to their pre-treatment baseline.

Obesity involves long-term changes in hormonal signaling and neurological pathways. Saxenda addresses those changes while it is active, but it does not permanently reset them. This is why many clinicians and professional guidelines now describe obesity as a chronic condition requiring ongoing management, similar to how high blood pressure or diabetes is treated.

For patients who respond well to liraglutide but face cost or access challenges, or those whose weight loss has plateaued, a transition to a higher-potency GLP-1 agent may be clinically appropriate. That is a conversation worth having with a prescriber before deciding to stop.

Factors That Shape Your Individual Response

Genetic variation in GLP-1 receptor sensitivity is a real phenomenon. Some patients have receptors that respond robustly to liraglutide, while others have variations that blunt the drug's effect. This is not something patients can control, but it does explain why two people on the same dose following the same diet can have very different outcomes.

Adherence to the full 3 mg therapeutic dose also matters more than many patients realize. A significant number of people who report that Saxenda stopped working are still on a sub-therapeutic dose because titration was paused due to side effects and never resumed. Staying at a lower dose can provide some appetite suppression but may not be enough to sustain meaningful weight loss.

Diet quality and physical activity continue to play a substantial role even with pharmacotherapy. Saxenda is approved as an adjunct to lifestyle changes, not a replacement for them. Patients who combine the medication with consistent behavioral strategies tend to see better and more durable results.

Evaluating Unexpected Weight Changes With a Clinician

If you notice a consistent upward trend of more than 5 pounds over 4 to 6 weeks while on a stable Saxenda dose, that warrants medical evaluation. A clinician should consider thyroid function, insulin resistance, possible medication interactions, and whether the current dose is truly therapeutic.

Doctronic offers free AI consultations available 24 hours a day, 7 days a week, with 99.2% treatment plan alignment with board-certified physicians. Whether you are trying to understand a plateau, a possible weight increase, or whether a different GLP-1 medication like semaglutide or tirzepatide might be a better fit, getting a personalized assessment is a practical first step before making any changes to your treatment plan on your own.

Frequently Asked Questions

Can Saxenda cause you to gain weight instead of losing it?

Saxenda does not have a direct mechanism that causes fat storage or weight gain. However, a small subset of patients in clinical trials did not lose weight or experienced modest gains, most likely due to compensatory eating, metabolic factors, or other medications. True pharmacological weight gain from liraglutide itself is not well supported by evidence.

Why am I gaining weight on liraglutide?

Possible reasons include behavioral rebound as nausea subsides at stable doses, an underlying condition like hypothyroidism or PCOS, concomitant medications such as antipsychotics or corticosteroids, or remaining on a sub-therapeutic dose. A clinician can help identify the specific cause and recommend whether a dose adjustment or additional evaluation is appropriate.

How much weight do you regain after stopping Saxenda?

Research suggests patients may regain roughly two-thirds of their lost weight within one year of discontinuing Saxenda. This happens because the GLP-1 hormone effect disappears quickly, restoring pre-treatment appetite signals. This rebound reflects the chronic nature of obesity and is an important expectation to discuss with a clinician before stopping treatment.

Does Saxenda cause water retention or bloating?

Fluid retention is not a documented side effect of liraglutide the way it is with some other medications. Bloating may occur as a gastrointestinal side effect, particularly during the dose titration phase, but edema-related weight gain from Saxenda is unlikely. If significant swelling is present, a clinician should evaluate for other possible causes.

What should I do if Saxenda stopped working for weight loss?

First, confirm you are on the full therapeutic dose of 3 mg. Then rule out interfering medications, thyroid dysfunction, or insulin resistance changes with a clinician. Switching to a higher-potency GLP-1 agent like semaglutide or tirzepatide may be an option if liraglutide response is inadequate. Avoid stopping the medication without medical guidance.

The Bottom Line

Liraglutide is not a direct pharmacological cause of weight gain. When Saxenda users see the scale move in the wrong direction, the explanation is usually found in behavioral patterns during dose adjustment, metabolic adaptation, undiagnosed conditions, or interactions with other medications. Weight regain after stopping Saxenda is real and well-studied, but it reflects the chronic biology of obesity rather than a flaw in the drug. Understanding these distinctions matters because stopping the medication prematurely can make long-term management harder. Doctronic, the first AI legally authorized to practice medicine in the United States, offers free AI consultations with 99.2% treatment plan alignment with board-certified physicians, available 24/7, making it an accessible way to evaluate whether your current Saxenda regimen needs adjustment or whether a different treatment path may be more appropriate. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.